Coronary Artery Bypass Graft Devices Market to Reach $1.38 Billion, Globally by 2032 at 3.7% CAGR: Allied Market Research

The global coronary artery bypass graft devices market is experiencing growth due to factors such as surge in prevalence of cardiovascular diseases, unhealthy diet and modern sedentary lifestyle, and rise in geriatric population. 

PORTLAND, Ore., Oct. 31, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Coronary Artery Bypass Grafts Device Market by Technology (Off-Pump, On-Pump, and Others), Product (Cardiopulmonary Bypass Machines, Endoscopic Vessel Harvesting Systems, Heart Positioners, Tissue Stabilizer, And Others) and End User (Hospitals, CardiologyCenters, and Others): Global Opportunity Analysis and Industry Forecast, 2023–2032". According to the report, the global coronary artery bypass grafts device market was valued at $0.96 billion in 2022 and is estimated to reach $1.38 billion by 2032, exhibiting a CAGR of 3.7% from 2023 to 2032. 

Request Sample of the Report on Coronary Artery Bypass Grafts Device Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/198433 

Coronary artery bypass graft (CABG) devices are vital instruments utilized in cardiac surgery for addressing coronary artery disease (CAD), a condition characterized by the narrowing or blockage of blood vessels supplying the heart muscle due to the accumulation of plaque. These devices are used to establish new routes for blood circulation, bypassing the diseased or blocked coronary arteries, which in turn enhances blood flow to the heart muscle. This effectively alleviates angina (chest pain) and diminishes the likelihood of a heart attack. 

Prime determinants of growth  

The coronary artery bypass graft devices market has experienced significant growth due to alarming increase in the prevalence of cardiovascular diseases worldwide, modern lifestyles, characterized by unhealthy dietary habits and sedentary routines, have become pervasive, contributing to a rise in risk factors such as obesity, hypertension, and diabetes and rise in geriatric population. However, the high cost of coronary artery bypass graft devices restrains the market growth. Moreover, a rise in awareness about heart health will offer remunerative growth opportunities to the market in the upcoming years. 

Report coverage & details: 

Economic Downturn Analysis: Impact of Recession in 2023 on the Coronary Artery Bypass Grafts Device Market

• The global recession has created a challenging environment for the coronary artery bypass graft devices market. 
• The high inflation rate for major key players of coronary artery bypass graft devices market has negatively impacted new product development and research activities. 
• However, the market for coronary artery bypass graft devices market is expected to recover owing to rise in prevalence of cardiac disorders. 

Want to Explore More, Connect to our Analyst- https://www.alliedmarketresearch.com/connect-to-analyst/198433 

 The tissue stabilizer segment to maintain its leadership status throughout the forecast period 

Based on product, the tissue stabilizer segment held the highest market share in 2022, accounting for around one third of the coronary artery bypass graft devices market revenue and is estimated to continue its supremacy throughout the forecast timeframe. This is attributed to high use of tissue stabilizer to ensure the proper stable surgical field. However, the heart positioners segment is expected to register the fastest growth CAGR of 4.5% during the forecasted period owing to high adoption of heart positioners to ensure a clear view of the surgical field. 

The hospital segment to maintain its leadership status throughout the forecast period 

Based on end user, the hospital segment held the highest market share in 2022, accounting for nearly two-thirds of the global coronary artery bypass graft devices market revenue. This is attributed to the high number of coronary artery bypass graft surgeries performed in the hospitals. The Cardiac centers segment, on the other hand, would cite the fastest growth with 4.8% CAGR from 2023 to 2032, owing to the fact that patients with chronic or stable coronary artery disease often visit cardiology clinics for regular check-ups, medical management, and treatment planning. 

The on-pump segment to maintain its leadership status throughout the forecast period 

Based on technology type, the on-pump segment held the highest market share in 2022, accounting for nearly three-fifths of the global coronary artery bypass graft devices market revenue, owing to high adoption of on-pump by surgeons as it provides stable surgical field. However, off pump segment is expected to register the fastest growth in the forecast period owing to the reduced risk of complications during the surgery. moreover, the off pump CABG segment would cite the fastest growth with 4.2% CAGR during the forecast period, owing to fact the Off-pump CABG is associated with reduced complications such as bleeding, stroke, and kidney dysfunction when compared to on-pump CABG. This makes it an attractive option for patients who want to minimize the risks associated with heart surgery. Furthermore, patients who undergo off-pump CABG often experience shorter hospital stays and faster recovery times.

For Procurement Information- https://www.alliedmarketresearch.com/purchase-enquiry/198433 

The North America segment to maintain its leadership status throughout the forecast period 

Based on region, the North America segment held the highest market share in 2022, accounting for more than two-fifths of the global coronary artery bypass graft devices market revenue. This is attributed to the rise in geriatric population, strong presence of major key players and well-developed healthcare infrastructure. However, the market across the Asia-Pacific region is expected to witness the fastest growth with 4.5% CAGR from 2023 to 2032. The growth is attributed to the rise in prevalence of coronary heart disease and favorable government initiatives such as national health insurance schemes. 

 Leading Market Players: - 

• Medtronic 
• Baxter International Inc. 
• Terumo Corporation 
• Peters Surgical Group 
• Getinge Ab 
• Genesee Biomedical Inc. 
• Transonic Systems Inc. 
• Livanova PLC 
• Condor Medtec Gmbh 
• Saphena Medical Inc.

The report provides a detailed analysis of these key players in the coronary artery bypass graft devices market. These players have adopted product launch to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario. 

Comprehensive Healthcare Industry Research Studies:

 Dialysis Market- Global Opportunity Analysis and Industry Forecast, 2022–2032

 Medical Electrodes Market- Global Opportunity Analysis and Industry Forecast, 2022–2032

 Tattoo Removal Market- Global Opportunity Analysis and Industry Forecast, 2022–2032

Neurovascular Devices Market- Global Opportunity Analysis and Industry Forecast, 2022–2032

 Elderly and Disabled Assistive Devices Market- Global Opportunity Analysis and Industry Forecast, 2022–2032 

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact

David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com  
Follow Us on: LinkedIn Twitter

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg 

SOURCE Allied Market Research